Recombinant human brain natriuretic peptide(Shijiazhuang wotai)
重组人脑利钠肽 (石家庄沃泰)
Report date: 2025/04/20 20:00:03
Base Information
Drug NameRecombinant human brain natriuretic peptide(Shijiazhuang wotai)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShijiazhuang wotai Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShijiazhuang wotai Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A